SCORE

49

BFRA: Biofrontera is a Sell


The current rating for BFRA is 49, which is 2% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.